Skip to main content Help with accessibility Skip to main navigation

ESKETAMINE nasal spray (Spravato®▼) for treatment-resistant depression

CCG Approval Status:

Date Added: 26 - Jan - 2023
Body System:
Black

The Cheshire and Merseyside Interim Area Prescribing Group does not recommend the prescribing of ESKETAMINE nasal spray (Spravato®▼) for treatment-resistant depression in adults in accordance with NICE TA854.

NHS Cheshire and Merseyside APPROVED